Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-26

Clinical Trial Update: Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy of levobupivacaine 0.125% versus ropivacaine 0.2% for hemodynamic changes and fetal effects during labor with epidural anesthe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • levobupivacaine 0.125% (levobupivacaine)
  • ropivacaine 0.2% (ropivacaine)

Snippet

Sponsor: Althaia Xarxa Assistencial Universitària de Manresa | Conditions: Hemodynamic Instability, Epidural | Phase 4 | Status: UNKNOWN